WASHINGTON (AP) - The Food and Drug Administration (FDA) expanded approval of a Pfizer drug to treat a rare form of pancreatic cancer.
MALVERN, Pa. (AP) - Auxilium Pharmaceuticals Inc. received a $7.5 million milestone from Pfizer following the launch of the specialty drug Xiapex in Germany.
Researchers at Indiana University identified a genetic biomarker that causes neuropathy among breast cancer patients using taxanes.
Prior Scientific’s H117P2NN flat top stage for the Nikon Ti series of inverted microscopes, can assist researchers conducting prolonged live cell studies.
FEI has extended its ChemiSTE Technology to enableatomic-level energy dispersive X-ray (EDX) spectroscopy across the periodic table.
Shire LLC has received a Paragraph IV Notice Letter from Sandoz Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of all strengths of VYVANSE.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, announced London-based Logos Technologies as a Medidata Technology Partner.
AMSBIO has announced the launch of the PluriPCR Kit, a new benchmark to revolutionize the definition of stem cell pluripotency. The PluriPCR kit has been designed as a quantitative and reliable assay of five genes strongly specific to pluripotency.
Greiner Bio-One North America, Inc. now offer the Cellmaster Roller Bottle product portfolio, designed to fulfill different requirements for the production of virus vaccines or recombinant proteins used for therapeutic approaches.
TxCell SA announces the approval by AFSSAPS, the French regulatory agency, of its application to extend treatment of patients included in the Crohn’s Disease phase 1/2 study with Ovasave, a type 1 regulatory T cell based immunotherapy.
TikoMed AB announced that TM-400 has been granted orphan drug designation for treatment to mobilize progenitor cells prior to stem cell transplantation by the European Medicines Agency.
Drugmaker Pfizer said that European regulators have approved its highly-anticipated blood thinner Eliquis to prevent blood clots in patients who have had hip or knee replacement surgery.
Drugmaker Merck & Co. said that a European drug agency has endorsed its hepatitis C treatment Victrelis, also known as boceprevir - a key step toward possible approval in the European Union.
The Food and Drug Administration said it approved a new HIV drug from Johnson & Johnson for patients who have not been treated with other medications for the virus.
Pearl Therapeutics Inc. presented efficacy and safety results in the company's Phase 2b study of PT003 (GFF MDI) in patients with moderate-to-very severe COPD at the annual meeting of the American Thoracic Society (ATS).